Compositions and methods for reducing at least one symptom of human allergy to cats
Compositions and methods reduce symptoms of human allergy to cats. The effectiveness of a molecule which specifically binds to Feline domesticus allergen number 1 (Fel D1) is enhanced by prolonging the time the immunoglobulin stays within the mouth of a cat to whom the anti-Fel D1 molecule is administered in a pet food. The compositions and methods use a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule, and the hydrogel is based on gelatin, collagen peptides, or gelatin and collagen peptides; and carrageenan. The methods of making the powder provide a high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the anti-Fel D1 molecule in the cat's mouth.
1. A method of making a food grade powder providing sustained release of an anti-Fel D1 molecule, the method comprising:
heating a solution comprising gelatin, carrageenan and the anti-Fel D1 molecule;
forming droplets of the heated solution;
gelling the droplets by subjecting the droplets to a gelling bath comprising salt or oil to form gelled beads in which the anti-Fel D1 molecule is encapsulated; and
drying the gelled beads to form the food grade powder.
2. The method of claim 1 , wherein the gelling bath comprises about 100 mM of potassium chloride, about 100 mM calcium chloride, or both.
3. The method of claim 1 , wherein the drying comprises subjecting the beads to fluid bed drying.
4. The method of claim 1 , wherein the gelatin and the carrageenan are the only biopolymers capable of gelling below 60° C. in the dried hydrogel.
5. A method of making a food grade powder providing sustained release of an anti-Fel D1 molecule, the method comprising:
heating a solution comprising gelatin, carrageenan, and the anti-Fel D1 molecule;
extruding the heated solution to cool and shape the heated solution and form an extruded hydrogel in which the anti-Fel D1 molecule is encapsulated; and
drying the extruded hydrogel.
6. The method of claim 5 , wherein the extruding is performed by a tubular heat exchanger having a temperature of about 0.1° C. to about 35° C.
7. The method of claim 5 , further comprising immersing the extruded hydrogel in a composition comprising calcium, magnesium potassium, rubidium, or cesium before the drying.
8. The method of claim 5 , wherein the drying comprises subjecting the extruded hydrogel to a drying tunnel, oven, or fluid bed drier.
9. A method of reducing symptoms of human allergy to a cat, the method comprising orally administering to the cat an effective amount of a food grade powder, wherein the food grade powder provides sustained release of an anti-Fel D1 molecule, wherein the food grade powder comprises a dried hydrogel and the anti-Fel D1 molecule, and wherein the dried hydrogel is a co-gel comprising carrageenan and a member selected from the group consisting of gelatin, collagen peptides, and gelatin and collagen peptides; wherein the anti-Fel D1 molecule is encapsulated in the dried hydrogel.
10. The method of claim 9 , wherein the composition is administered as part of a pet food further comprising at least one component selected from the group consisting of protein, fat, carbohydrate, vitamin and mineral.
11. The method of claim 9 , wherein the gelatin or the gelatin and collagen peptides are from Type A porcine gelatin having a positive charge at a pH below 7.0.
12. The method of claim 9 , wherein the carrageenan is selected from the group consisting of (i) kappa-carrageenan, (ii) iota-carrageenan, (iii) a physical mixture of kappa-carrageenan and iota-carrageenan and (iv) a co-polymer of kappa-carrageenan and iota-carrageenan.
13. The method of claim 9 , wherein the gelatin and the carrageenan are the only biopolymers in the dried hydrogel.
14. The method of claim 9 , wherein the dried hydrogel is a spray-dried hydrogel comprising the anti-Fel D1 molecule and 0.5 to 90 wt. % of gelatin, and the powder has a density of about 0.265 to about 0.3 g/cm 3 .
15. The method of claim 14 , wherein the gelatin and collagen peptides have a molecular weight between 2,000 and 1 million Daltons and a bloom value of 40 to 300.
16. The method of claim 14 , comprising 25.0 to 60.0 wt. % of the gelatin and 40 to 75 wt. % of a source of the anti-Fel D1 molecule.